View in EDS HTML Full Text PDF Full Text

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.

Saved in:
Bibliographic Details
Title: Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.
Authors: Pivonello R; Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy., Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A, Schopohl J, Biller BM
Corporate Authors: Pasireotide B2305 Study Group
Source: Clinical endocrinology [Clin Endocrinol (Oxf)] 2014 Sep; Vol. 81 (3), pp. 408-17. Date of Electronic Publication: 2014 Mar 27.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Publishing Country of Publication: England NLM ID: 0346653 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2265 (Electronic) Linking ISSN: 03000664 NLM ISO Abbreviation: Clin Endocrinol (Oxf) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24533697
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pivonello+R%22">Pivonello R</searchLink>; Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Petersenn+S%22">Petersenn S</searchLink><br /><searchLink fieldCode="AU" term="%22Newell-Price+J%22">Newell-Price J</searchLink><br /><searchLink fieldCode="AU" term="%22Findling+JW%22">Findling JW</searchLink><br /><searchLink fieldCode="AU" term="%22Gu+F%22">Gu F</searchLink><br /><searchLink fieldCode="AU" term="%22Maldonado+M%22">Maldonado M</searchLink><br /><searchLink fieldCode="AU" term="%22Trovato+A%22">Trovato A</searchLink><br /><searchLink fieldCode="AU" term="%22Hughes+G%22">Hughes G</searchLink><br /><searchLink fieldCode="AU" term="%22Salgado+LR%22">Salgado LR</searchLink><br /><searchLink fieldCode="AU" term="%22Lacroix+A%22">Lacroix A</searchLink><br /><searchLink fieldCode="AU" term="%22Schopohl+J%22">Schopohl J</searchLink><br /><searchLink fieldCode="AU" term="%22Biller+BM%22">Biller BM</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Pasireotide+B2305+Study+Group%22">Pasireotide B2305 Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220346653%22">Clinical endocrinology</searchLink> [Clin Endocrinol (Oxf)] 2014 Sep; Vol. 81 (3), pp. 408-17. <i>Date of Electronic Publication: </i>2014 Mar 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Publishing%22">Blackwell Publishing </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0346653 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203000664%22">03000664 </searchLink><i>NLM ISO Abbreviation: </i>Clin Endocrinol (Oxf) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24533697
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cen.12431
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 408
    Titles:
      – TitleFull: Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pivonello R
      – PersonEntity:
          Name:
            NameFull: Petersenn S
      – PersonEntity:
          Name:
            NameFull: Newell-Price J
      – PersonEntity:
          Name:
            NameFull: Findling JW
      – PersonEntity:
          Name:
            NameFull: Gu F
      – PersonEntity:
          Name:
            NameFull: Maldonado M
      – PersonEntity:
          Name:
            NameFull: Trovato A
      – PersonEntity:
          Name:
            NameFull: Hughes G
      – PersonEntity:
          Name:
            NameFull: Salgado LR
      – PersonEntity:
          Name:
            NameFull: Lacroix A
      – PersonEntity:
          Name:
            NameFull: Schopohl J
      – PersonEntity:
          Name:
            NameFull: Biller BM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2014 Sep
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2265
          Numbering:
            – Type: volume
              Value: 81
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical endocrinology
              Type: main
ResultId 1